Welcome back to the working week. We hope the weekend was invigorating and refreshing, because now those mountains of meetings and deadlines are looming. We relate, of course, and are brewing the mandatory cup of stimulation to help us along. As always, you are invited to join us. So grab a cup and peruse some of the tidbits below. Hopefully, these will help as you navigate the day. Meanwhile, best of luck and drop us a line if you come across anything interesting...
Ranbaxy To Expand Mohali Unit For US Market (Business Standard)
Enzon Pharma To Explore Sale Of Company (Reuters)
To Cut Costs, France Pushes Generics (Bloomberg News)
Merck CEO Discusses Healthcare After The Fiscal Cliff (Forbes)
US Branded Rx Revenue To Drop 3.5 Percent In 2012: Study (Pharma Times)
Lundbeck Sees Ties To Depression Boosting Binge-Drinking Pill (Bloomberg News)
Teva Enters Korean Market With Hendok Venture (Reuters)
Novartis Wins FDA Approval For Cushing's Disease Drug (Bloomberg News)
Amarin Shares Sink On FDA NCE Delay (TheStreet)
Court Upholds AstraZeneca's US Patent For Crestor (Thomson Reuters)
EDITOR'S NOTE: Please check this post for updates
steaming coffee pic thx to dleggett on flickr